Business Context and Reporting Period
This Form 8-K Current Report, dated April 21, 2020, details significant capital restructuring activities by Senseonics Holdings, Inc. The filing reports the entry into a new loan agreement and a debt-for-equity exchange transaction with funds managed by Highbridge Capital Management, LLC. The transactions are expected to close on or about April 24, 2020.
Key Financial Metrics and Transaction Terms
The filing outlines two primary financial instruments and their associated terms:
- Highbridge Loan Agreement (First Lien Notes):
- Total borrowing capacity: $20.0 million.
- Initial tranche: $15.0 million principal amount.
- Interest rate: 12% cash or 13% payment-in-kind (PIK).
- Maturity: October 24, 2021.
- Commitment Fee: 1,500,000 shares of Common Stock.
- Exchange Agreement (Second Lien Notes):
- Exchange of $24.0 million of outstanding 5.25% Senior Convertible Notes due 2025.
- New issuance: $15,675,000 aggregate principal of Second Lien Secured Notes.
- Interest rate: 7.5% cash or 8.25% PIK.
- Maturity: January 24, 2022.
- Equity consideration: 11,026,086 shares of Common Stock and warrants to purchase 4,500,000 shares at $0.66 per share.
The filing does not provide specific revenue, profit, or cash flow figures for the reporting period, as this is a current report focused on material agreements rather than periodic financial results.
Material Changes and Debt Restructuring
The Company is materially altering its capital structure by replacing existing unsecured convertible debt with new secured debt and equity. Key changes include:
- Debt Conversion: $24.0 million of 2025 Notes are being exchanged for a mix of new secured notes ($15.675 million), equity, and warrants.
- Increased Leverage and Interest Costs: The new First Lien Notes carry a significantly higher interest rate (12-13%) compared to the existing 5.25% notes, though the new debt is secured by substantially all assets.
- Equity Dilution: The transactions involve the immediate issuance of approximately 12.5 million shares of Common Stock (1.5 million commitment fee shares + 11.026 million exchange shares), plus potential future dilution from warrants and conversion features.
- Covenants: The agreements impose financial covenants, including maintaining a minimum cash balance and operating within an approved budget, alongside negative covenants restricting indebtedness, liens, and asset transfers.
Guidance, Risks, and Contingencies
Use of Proceeds: The Company expects to use the proceeds from the First Lien Notes for working capital and general corporate purposes.
Stockholder Approval: The Company is restricted from issuing shares in excess of 19.99% of the Common Stock outstanding (net of shares underlying the exchanged 2025 Notes) without stockholder approval. The Company intends to seek this approval at its 2020 Annual Meeting.
Registration Rights: The Company must file a Form S-3 registration statement by April 29, 2020, and have it declared effective within 45 days. Failure to do so will trigger additional interest penalties on the Senior Notes, starting at 0.50% annually and increasing by 0.50% every 90 days up to a 2.0% aggregate increase.
Risks: Forward-looking statements highlight risks related to the uncertainty of strategic transactions, regulatory approval processes, the impact of the COVID-19 pandemic, and the ability to consummate the proposed transactions.
Investor Verification Checklist
- Verify the closing of the $15.0 million First Lien Notes and the exchange of $24.0 million of 2025 Notes on or about April 24, 2020.
- Confirm the filing and effectiveness of the Form S-3 registration statement by the April 29, 2020 deadline to avoid penalty interest.
- Monitor the outcome of the 2020 Annual Meeting of Stockholders regarding the 19.99% issuance cap.
- Review the Company's cash balance to ensure compliance with the new minimum cash balance covenant.
- Assess the impact of the new 12-13% interest rates on the Company's liquidity and burn rate.